plexus glp 1 product Supplement brands launch gut health and GLP-1 products Neurobiological Mechanisms and Therapeutic Potential
Description
Listen to the Full Episode Curious to learn more about microdosing GLP-1s and how they fit into a holistic health approach
The Opdivo combo is the first concurrent immunotherapy-chemotherapy combination approved for this patient population in the U.S., according to BMSs press release
However, clinical trials have been known to show that tirzepatide can be a significant factor in lessening the risk of type 2 diabetes by up to 10 years in people with overweight or obesity
Top concerns with using GLP-1s for weight loss are predatory pharmaceutical marketing practices (70%), supply chain issues for diabetes patients (63%), and prescribing behavior
Treatment selection is individualized and based on medical history, therapeutic goals, tolerability, and provider guidance
